The COVID-19 pandemic has laid bare the drivers behind care disparities - particularly for communities of color - and presents a call to action for all to address structural inequities across healthcare and scientific research. The Health Equity Innovations Fund invites proposals to support groundbreaking efforts to address healthcare disparities for historically underserved communities, with a focus on communities of color. This can yield benefits for society as a whole, laying the groundwork for more relevant and widely applicable healthcare solutions, reducing avoidable healthcare spending, and ensuring equitable health outcomes for all people.
The Medically Trained Scientists Program (MTS) welcomes applications from individuals who have trained in medicine and are committed to academic careers in basic, fundamental biomedical research.
Emergency Medicine Foundation—FUJIFILM SonoSite COVID-19 Point of Care Ultrasound Acceleration Research Grant
We are in a global COVID-19 pandemic with over 9 million confirmed cases and over 470K deaths as of June 23, 2020. This disease has affected 188 countries with certain countries having a disproportionate morbidity and mortality. Diagnostic imaging for COVID-19 has included X-ray and CT scanning but ultrasound has significant cost and time advantages. Furthermore critically ill patients with COVID-19 can have multi-organ failure in which point of care ultrasound can help for multiple purposes. Within four months, publications have shown the value of point of care ultrasound in COVID-19 patients, but the work is still preliminary and more formal research is necessary. In an effort to further learn and evaluate the role of ultrasound in COVID-19 a dedicated EMF research grant will be sponsored by FUJIFILM SonoSite to encourage study into this deadly disease.
The diagnosis of ATTR-CM is complex and often requires patients to undergo many diagnostic procedures with multiple specialists. The nurse navigator is an important member of the healthcare team who provides care in a highly supportive and personal manner and also helps to guide and support patients and their families through the patient diagnostic and treatment journey.
Johnson & Johnson Innovation—JLABS (“JLABS”), in collaboration with Seoul Metropolitan Government (“SMG”), Korea Health Industry Development Institute (“KHIDI”), Janssen Korea Ltd., is launching the Seoul Innovation QuickFire Challenge for Healthcare in the New Normal.
The HHMI Investigator Program supports nearly 300 Investigators, located at more than 60 research institutions across the United States, who are widely known for their scientific discoveries, their innovation, and their success in pushing the bounds of knowledge in biomedical research.
During the COVID-19 pandemic, the need for telehealth to deliver patient care has increased. Through this RFP, it is Pfizer’s intent to support programs focused on the education of healthcare practitioners (HCPs) to better leverage technology and utilize telehealth to optimize the hormone therapy benefit/risk discussion with postmenopausal patients.
Due to the disruptions caused by the COVID-19 pandemic, there is a critical need for Telemedicine programs for patients with Inflammatory Conditions, including Rheumatoid Arthritis (RA), Atopic Dermatitis (AD), and Ulcerative Colitis (UC).
Through this RFP, it is Pfizer’s intent to support educational programs for pediatric endocrinologists.
Provider education should be in the following therapeutic areas: autoimmune, endocrine, neurodegeneration, neuroscience (migraine and headache disorders), oncology, chronic pain associated with ost